Nano-X Imaging Ltd.

NASDAQ:NNOX

Medical - Devices

Healthcare
$0.73 -1.45%

-$0.03 today

Market cap
$50.94M
Beta
1.17
P/E (TTM)
-1.5
EPS (TTM)
-$1.12
52W Low $1.59High $5.69

Volume 0.52M

Average 1.46M

NNOX Deferred Revenue

Payments received for goods or services the company will deliver within the next year.

Nano-X Imaging Ltd.NASDAQ: NNOX

Deferred Revenue · Q4 FY2025 · quarter ended Dec 2025

Deferred revenue rises 281.4% from a year ago

Deferred revenue stood at $534K at the end of Q4 FY2025, up 281.4% from a year earlier and up 95.6% from the prior quarter. Over 3 fiscal years it compounded at +43.2% a year.

Context

  • Deferred revenue amounted to 0.3% of total assets at the end of Q4 FY2025, up 0.3 pp from a year earlier.
  • Deferred revenue increased in 2 of the last 3 fiscal years.

What to watch

Whether deferred revenue keeps rising in the next quarterly balance sheet after a +281.4% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterDec 2025
$534K+95.6% QoQ
Last fiscal yearDec 2025
$534K+281.4% YoY
Year agoDec 2024
$140K+281.4% since
Deferred Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+281.4%——
1 year+281.4%——
3-year CAGR+43.2%——
5-year CAGR——
10-year CAGR——

Deferred Revenue history

USD · from the balance sheet

Latest · FY2025
534K USD
Year-over-year change
+281.4%
4-year CAGR
+21.3%

Deferred Revenue vs competitors

How NNOX compares with its peers on the latest reported figures

  • NNOX's Dec 2025 deferred revenue of $534K is the 7th highest of the 11 companies compared; the peer median is $4.18M.
  • Its year-over-year change of +281.4% is the highest of 9, against a peer median of -20.8%.
  • Deferred revenue amounts to 0.3% of total assets for NNOX, versus a peer median of 1.7%.
NNOX Competitors Peer median
Deferred Revenue for NNOX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
HCATHealth Catalyst, Inc.Mar 2026$69.74M -2.5%+0.7%16.9%
CATXPerspective Therapeutics, Inc.Mar 2026$26.6M ——6.5%
QTRXQuanterix CorporationMar 2026$15.19M +66.9%+33.8%4.1%
OMOutset Medical, Inc.Mar 2026$12.64M -4.2%+16.8%5.1%
INGNInogen, Inc.Mar 2026$5.09M -20.6%-14.7%1.8%
MXCTMaxCyte, Inc.Mar 2026$3.27M -21.1%—1.7%
NNOXNano-X Imaging Ltd.Dec 2025$534K +281.4%+43.2%0.3%
PROFProfound Medical Corp.Mar 2026$465.53K -26.8%—0.6%
TLSITriSalus Life Sciences, Inc.Mar 2026$0 ——0.0%
HSDTSolana CompanyMar 2026$0 -100.0%—0.0%
SNWVSANUWAVE Health, Inc.Mar 2026$0 -100.0%+86.3%0.0%
Peer median (excluding NNOX) $4.18M-20.8%+16.8%1.7%

Competitors are the stored peer set for NNOX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents66.65M38.46M56.38M39.3M49.15M
Short-term Investments22.07M39.16M26.01M33.9M10.46M
Net Receivables1.05M977K1.48M1.81M2.01M
Inventory3.13M2.41M2.36M1.49M3.07M
Other Current Assets1.97M1.45M1.14M1.35M2.1M
Total Current Assets94.86M82.46M88.64M78.68M66.79M
Property, Plant & Equipment (Net)39.16M44.7M46.92M49.2M33.2M
Goodwill58.3M7.42M00316K
Intangible Assets101.83M91.22M80.61M70M59.87M
Long-term Investments67.85M25.2M327K337K361K
Tax Assets00000
Other Non-current Assets1.18M2.93M2.16M11.79M1.63M
Total Non-current Assets268.31M171.47M130.01M131.32M95.37M
Total Assets363.17M253.93M218.65M210M162.17M
Account Payables3.13M3.62M3.3M2.21M2.89M
Short-term Debt145K03.49M3.06M3.14M
Tax Payables00000
Deferred Revenue247K182K543K140K534K
Other Current Liabilities44.73M8.29M3.41M3.85M5.16M
Total Current Liabilities52.75M25.07M15.52M13.97M16.89M
Long-term Debt3.8M3.48M000
Deferred Tax Liabilities7.06M3.33M2.95M2.58M600K
Deferred Revenue (Non-current)415K398K0017K
Other Non-current Liabilities6.05M4.57M612K695K1.16M
Total Non-current Liabilities18.27M12.18M7.61M6.91M5.54M
Total Liabilities71.02M37.25M23.13M20.88M22.43M
Common Stock149K158K165K181K198K
Retained Earnings(146.21M)(259.46M)(320.23M)(373.75M)(448.77M)
Accumulated OCI(607K)(1.97M)(305K)(1K)0
Other Stockholders Equity00000
Minority Interest00000
Total Equity292.15M216.68M195.51M189.12M139.73M
Total Debt5.77M4.62M8.4M7.45M7.85M
Net Debt(60.87M)(33.84M)(47.98M)(31.86M)(41.3M)

Nano-X Imaging Ltd.

NASDAQ:NNOX

Intrinsic Alpha fair value

Locked

Current Price

$0.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.